retatrutide mechanism triple agonist glp-1 gip glucagon ly3437943 Retatrutide is not “just another GLP1.” It retatrutide mechanism triple agonist gip

As we learn more, the hope is to make treatment more personal, more effective, and easier to track

However, these agents increase risk of intra-operative pulmonary aspiration according to a case report secondary to delayed emptying and presence of gastric residues despite fasting (108, 108) To prevent these events, the recent recommendations from the American Society of Anesthesiology guidelines suggest discontinuing GLP-1 receptor agonists 1 day prior in patients on daily dosing and 1 week prior in patients on weekly injection dosing (108)

In the coming years, patients and providers will have the options of newly launched biosimilars, novel GLP-1s, combination drugs, and approvals for allied indications

What are these medications, and how do they work

45, 2021;Puhl, R